arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

TELEFLEX INC

TFX
$121.75 ▼ -3.17 (-2.54%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
72 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
30
Health
Poor
Bearish
auto_awesome

Analytical Summary

TELEFLEX INC faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $5.3B
Dividend Yield 0.28%
Revenue Growth -27.0%
Op. Margin 12.8%
ROIC 1.2%
FCF / Share
Trailing P/E 53.2x
Price / Book 1.8x
FCF Yield
Debt / Equity 0.97
info Valuation on last close. End-of-day price, Sep 23, 2026.

72-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$570.33M
↓ -27.0%
Net Income Profit after all expenses
$-8.15M
— 0.0%
Operating Margin Operating profit as % of sales
12.8%
↑ +246.9% 46th
Long-Term Debt Long-term obligations
$2.81B
↑ +11.7%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
26
Returns
24
Financial Health
44

Dividend History

Dividend / share · sourced from SEC filings
$1.36 Latest / share
+0.0% YoY
+0.0% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 19 years · 72 quarters